About Us

ABOUT USA Bangor University Spin Out, Based On Leading Edge Technology

Established in 2015 as a Point of Care (PoC) diagnostics company to deliver unique devices for the diagnosis of Mycobacterial infections, utilising novel mycolic acid antigens.

Situated within M-SParc, a unique science park that brings together companies of all sizes. Encouraging both innovation and collaboration, within high-spec laboratories and a friendly environment.

CORE TECHNOLOGYFully Synthetic Mycolic Acids

Unique compounds that are potent and selective signalling agents in the immune system

Mycolic acids are unique to mycobacteria and responsible for many of their properties.

Synthetic mycolic acids and other cell wall components of mycobacteria are useful in a number of areas including:

Diagnostic Testing
Vaccine Adjuvants
Prophylactic and therapeutic agents
Asthma Treatment
Anti-cancer Agents

OUR TEAMA small but dedicated team of scientists

https://www.diagnostig.com/wp-content/uploads/2021/02/mark.jpg

Prof. Mark Baird

Managing Director

https://www.diagnostig.com/wp-content/uploads/2021/02/malcolm.jpg

CHAIRMAN, IP MANAGERDr. Malcolm Jones

https://www.diagnostig.com/wp-content/uploads/2021/02/don.jpg

CHIEF COMMERCIAL OFFICERDr. Don Cardy

https://www.diagnostig.com/wp-content/uploads/2020/11/dafydd.jpg

RESEARCH AND DEVELOPMENT SCIENTISTDr. Dafydd Thomas

https://www.diagnostig.com/wp-content/uploads/2020/11/anna.jpg

RESEARCH AND DEVELOPMENT SCIENTISTAnna Cervi